IPO Timeline
Broker Results (T-2)
2021-07-05
Some brokers release in afternoon
Grey Market (T-1)
2021-07-06
Afternoon
HKEX Allotment (T-1)
2021-07-06
Evening
Registrar Allotment (T-1)
2021-07-06
Evening
Listing Day (T)
2021-07-07
First day of trading
Company Overview
| Stock Name | 朝聚眼科醫療控股有限公司 |
|---|---|
| Stock Code | 02219 |
| Company Full Name | 朝聚眼科醫療控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事經營眼科醫院及視光中心。 |
| Listing Date | 2021-07-07 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市豐臺區西三環南路14號院首科大廈A座東區24層 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.chaojueye.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 10.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 43.7% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 905,929,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 14.1 |
|---|---|
| First Day Open | HK$ 10.6 |
| First Day Change | 33.02% |
| First Day Volume | 165726000.0 |
| First Day Turnover | 2121820000.0 |
Use of Proceeds
| Use of Proceeds | 1、約35.8%（或485.5百萬港元）將用于建立新醫院以及搬遷、升級及裝修現有醫院； 2、約44.8%（或608.4百萬港元）將在出現合適機遇時，用于在人口龐大且對眼科醫療服務需求相對較高的新市場中收購醫院； 3、約9.4%（或127.5百萬港元）將用于升級我們的信息技術系統； 4、約10.0%（或135.7百萬港元）將用于營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
海通国际资本有限公司 CE ADQ859
华泰金融控股（香港）有限公司 CE AOK809
Overall Coordinators (2)
海通国际证券有限公司 CE AAF806
华泰金融控股（香港）有限公司 CE AOK809
Joint Bookrunners (2)
海通国际证券有限公司 CE AAF806
华泰金融控股（香港）有限公司 CE AOK809
Joint Lead Managers (2)
海通国际证券有限公司 CE AAF806
华泰金融控股（香港）有限公司 CE AOK809
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Gigantic Wealth Holdings Limited | 155,205,200 HKD | — | 8.57% | — | 6 months | 2022-01-07 |
| 2 | The Valliance Fund | 155,205,200 HKD | — | 8.57% | — | 6 months | 2022-01-07 |
| 3 | 富国基金管理有限公司 | 349,217,000 HKD | — | 19.27% | — | 6 months | 2022-01-07 |
| 4 | 通柏资本(香港)有限公司 | 131,922,300 HKD | — | 7.28% | — | 6 months | 2022-01-07 |
Directors & Management
| Chairman | 張波洲 |
|---|---|
| Company Secretary | 羅偉健;張光弟 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 張波洲及關連人士(14.08%);張小利(11.91%);王暉及關連人士(11.1%);Orchid Asia VII, L.P.(9.7%);張俊峰(8.47%) |
|---|
IPO Timeline
